This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What to Expect for Intercontinental Exchange (ICE) Q4 Earnings
by Zacks Equity Research
Intercontinental Exchange's (ICE) Q4 results are likely to reflect a positive momentum from its data revenues and lower expenses.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
MarketAxess (MKTX) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
MarketAxess (MKTX) Q4 results reflect increase in revenues on higher trading volumes, partly offset by rise in expenses.
The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), McDonald's (MCD) and Bristol-Myers Squibb (BMY).
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
The Zacks Analyst Blog Highlights: Danaher, Petrobras, Fiserv, CME and ConocoPhillips
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher, Petrobras, Fiserv, CME and ConocoPhillips
Top Stock Reports for Danaher, Petrobras & Fiserv
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Danaher (DHR), Petrobras (PBR) and Fiserv (FISV).
Trade of the 2020's: Sell Gold, Buy Biotech
by Kevin Cook
In 5 years, you be selling your gold and buying more companies leading the century of biology.
Here's Why MarketAxess (MKTX) Stock Looks Attractive Now
by Zacks Equity Research
MarketAxess (MKTX) benefits from growth in business and market share, acquisitions, innovation, and strong capital position.
Baidu, Live Nation Entertainment, CME, MarketAxess and Nasdaq highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Baidu, Live Nation Entertainment, CME, MarketAxess and Nasdaq highlighted as Zacks Bull and Bear of the Day
CME Group (CME) to Launch Bitcoin Options in Early 2020
by Zacks Equity Research
CME Group (CME) unveils options on Bitcoin Futures to help clients in hedging bitcoin price risk.
Intercontinental (ICE) to Launch Futures Exchange in Abu Dhabi
by Zacks Equity Research
Intercontinental Exchange's (ICE) futures exchange to enable trading in Murban crude-oil future contracts.
MarketAxess (MKTX) Up 70% This Year: Is Further Upside Left?
by Zacks Equity Research
MarketAxess (MKTX) is driven by growth in business and market share and strong capital position.
Solid Near-Term Outlook for Securities and Exchanges Industry
by Tanuka De
Securities and Exchanges industry is poised for growth given product innovation, increased market volatility and a strategic economic market model.
Cboe Global's (CBOE) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cboe Global Markets (CBOE) third-quarter 2019 earnings reflect higher trading volumes.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
Stock Market News For Oct 31, 2019
by Zacks Equity Research
Benchmarks closed in the green on Wednesday as the Federal Reserve cut rates for the third time this year, and Chairman Jerome Powell signaled no rate hikes until he witness a "really significant" rise in inflation.
How to Replicate a Stock Postion Using Options
by David Borun
Options can be a way around account restrictions, but not negative interest rates
CME Group (CME) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
CME Group's (CME) third-quarter 2019 results reflect solid trading volumes.
CME Group (CME) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 8.57% and 0.60%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
CME Group Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
CME Group has been struggling lately, but the selling pressure may be coming to an end soon.
CME Group (CME) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group (CME) Q3 earnings are likely to have benefited from expanded futures products, OTC offerings and higher clearing and transaction fees.
MarketAxess (MKTX) Beats Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Growth in trading volumes aids MarketAxess' (MKTX) Q3 results.